HomeCompareHRPMF vs PLD

HRPMF vs PLD: Dividend Comparison 2026

HRPMF yields 56.98% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.94M in total portfolio value· pulled ahead in Year 8
10 years
HRPMF
HRPMF
● Live price
56.98%
Share price
$3.51
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$561.2K
Annual income
$126,052.94
Full HRPMF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — HRPMF vs PLD

📍 PLD pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRPMFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRPMF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRPMF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRPMF
Annual income on $10K today (after 15% tax)
$4,843.30/yr
After 10yr DRIP, annual income (after tax)
$107,145.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,360,825.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRPMF + PLD for your $10,000?

HRPMF: 50%PLD: 50%
100% PLD50/50100% HRPMF
Portfolio after 10yr
$3.53M
Annual income
$2,691,244.56/yr
Blended yield
76.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

HRPMF
No analyst data
Altman Z
-40.5
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRPMF buys
0
PLD buys
0
No recent congressional trades found for HRPMF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRPMFPLD
Forward yield56.98%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$561.2K$6.50M
Annual income after 10y$126,052.94$5,256,436.18
Total dividends collected$460.7K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HRPMF vs PLD ($10,000, DRIP)

YearHRPMF PortfolioHRPMF Income/yrPLD PortfolioPLD Income/yrGap
1$16,398$5,698.01$11,255$555.24+$5.1KHRPMF
2$26,278$8,732.33$13,062$1,018.59+$13.2KHRPMF
3$41,196$13,078.29$15,903$1,926.67+$25.3KHRPMF
4$63,241$19,161.35$20,839$3,823.32+$42.4KHRPMF
5$95,159$27,490.76$30,464$8,166.08+$64.7KHRPMF
6$140,479$38,659.15$52,054$19,457.30+$88.4KHRPMF
7$203,650$53,337.34$109,886$54,188.93+$93.8KHRPMF
8← crossover$290,169$72,263.73$304,030$186,451.18$13.9KPLD
9$406,709$96,228.48$1,166,125$840,813.32$759.4KPLD
10$561,232$126,052.94$6,504,190$5,256,436.18$5.94MPLD

HRPMF vs PLD: Complete Analysis 2026

HRPMFStock

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

Full HRPMF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this HRPMF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRPMF vs SCHDHRPMF vs JEPIHRPMF vs OHRPMF vs KOHRPMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.